Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

The novel cap-dependent endonuclease inhibitor baloxavir marboxil was approved for the treatment of influenza virus infection in Japan in February 2018. Two influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic subunit (PA) were detected in baloxavir-treated children in De...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashita, Emi, Kawakami, Chiharu, Morita, Hiroko, Ogawa, Rie, Fujisaki, Seiichiro, Shirakura, Masayuki, Miura, Hideka, Nakamura, Kazuya, Kishida, Noriko, Kuwahara, Tomoko, Mitamura, Keiko, Abe, Takashi, Ichikawa, Masataka, Yamazaki, Masahiko, Watanabe, Shinji, Odagiri, Takato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344841/
https://www.ncbi.nlm.nih.gov/pubmed/30670142
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.3.1800698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344841/
https://www.ncbi.nlm.nih.gov/pubmed/30670142
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.3.1800698

Ejemplares similares